Searchable abstracts of presentations at key conferences in endocrinology

ea0029p520 | Diabetes | ICEECE2012

Mesenchymal stem cells-derived microvesicles modulate cellular immune response to islet antigen GAD in type 1 diabetes.

Favaro E. , Deregibus M. , Camussi E. , Granata R. , Ghigo E. , Cavallo Perin P. , Zanone M. , Camussi G.

Background and aims: Mesenchymal stem cells (MSCs) exert an immunosuppressive effect on immune system and can abrogate in vitro the pro-inflammatory Th1 response to islet antigen GAD in type 1 diabetes by impairing the production of IFN-gamma. The mechanism may involve paracrine factors. Microvesicles (MVs) released from MSCs may account for this paracrine mechanism through a horizontal transfer of mRNA and microRNA. In the present study we evaluated whether MSC-derived...